Recruiting NA Chronic Ankle Instability, CAI

New treatment option for Chronic Ankle Instability, CAI

Official title Ankle vs. Hip vs. Combined Strengthening in Chronic Ankle Instability

ClinicalTrials.gov ID: NCT07606534

What this study is testing

What it's testing
Chronic ankle instability (CAI) is a common condition that can develop after a lateral ankle sprain. Up to 40% of people who sprain their ankle experience a recurrence within a year, and as many as 30% develop persistent symptoms such as ankle "giving way," weakness, or instability.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 35

You may be able to join if

  • Have a history of at least one major ankle sprain that occurred at least 12 months prior to enrolment in the study, was associated with inflammatory...
  • Have had at least two episodes of feeling like an "unstable" ankle in the six months preceding the study.
  • The Cumberland Ankle Instability Tool (CAIT) with a score of less than 24.
  • The Foot and Ankle Ability Measure (FAAM) Sport scale with a score below 80%.
  • Between 18 and 35 years old

You likely can't join if

  • Have had a recent injury of less than three months prior to enrolment in the study.
  • A history of surgery on the musculoskeletal structures of the lower limbs.
  • Have a history of fracture of one of the lower limbs requiring realignment.
  • Being diagnosed with a neuromuscular disease.
  • The appearance of swelling or pain in the lower limb during the experiment.
See the full eligibility criteria
Who can join
  • Have a history of at least one major ankle sprain that occurred at least 12 months prior to enrolment in the study, was associated with inflammatory symptoms (pain, swelling, etc), created at least one interrupted day...
  • Have had at least two episodes of feeling like an "unstable" ankle in the six months preceding the study.
  • The Cumberland Ankle Instability Tool (CAIT) with a score of less than 24.
  • The Foot and Ankle Ability Measure (FAAM) Sport scale with a score below 80%.
  • Between 18 and 35 years old
  • Must be able to understand the study procedures and provide written informed consent
What rules you out
  • Have had a recent injury of less than three months prior to enrolment in the study.
  • A history of surgery on the musculoskeletal structures of the lower limbs.
  • Have a history of fracture of one of the lower limbs requiring realignment.
  • Being diagnosed with a neuromuscular disease.
  • The appearance of swelling or pain in the lower limb during the experiment.

The study team makes the final eligibility decision.

Where it's taking place

  • Liège, Belgium

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 35 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Liège, Belgium. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.